» Articles » PMID: 10832032

Photosensitizing Activity of Hematoporphyrin on Staphylococcus Aureus Cells

Overview
Specialties Biochemistry
Biophysics
Date 2000 Jun 1
PMID 10832032
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The photosensitizing action of hematoporphyrin (Hp) on two Staphylococcus aureus strains was investigated to determine if the photoprocess induces in vivo damage in DNA in addition to that occurring at the level of the cytoplasmic membrane. The results obtained demonstrate that the photokilling is dependent on the Hp dose even though the two strains, having a similar Hp-binding capacity, show different levels of photosensitivity. The electrophoretic analysis of cytoplasmic membrane proteins and DNA (chromosomal and plasmidial) suggests that the membrane represents the primary target of the photoprocess, while the DNA, that is damaged both in vivo and in vitro only at relatively long irradiation time, might be a secondary target. Moreover, the photoprocess results in mutagenesis for Salmonella typhimurium tester strains. This information is particularly important in view of the potential use of photodynamic therapy for the treatment of microbial infections.

Citing Articles

Porphyrin-Polymer as a Photosensitizer Prodrug for Antimicrobial Photodynamic Therapy and Biomolecule Binding Ability.

Tabrizi L, McGarry R, Turzanska K, Varvarezos L, Fallon M, Brannigan R Biomacromolecules. 2024; 25(12):7736-7749.

PMID: 39514700 PMC: 11632779. DOI: 10.1021/acs.biomac.4c01011.


Effects of Antimicrobial Photosensitizers of Photodynamic Therapy (PDT) to Treat Periodontitis.

Bourbour S, Darbandi A, Bostanghadiri N, Ghanavati R, Taheri B, Bahador A Curr Pharm Biotechnol. 2023; 25(10):1209-1229.

PMID: 37475551 DOI: 10.2174/1389201024666230720104516.


Antimicrobial photodynamic therapy against oral biofilm: influencing factors, mechanisms, and combined actions with other strategies.

Li Y, Sun G, Xie J, Xiao S, Lin C Front Microbiol. 2023; 14:1192955.

PMID: 37362926 PMC: 10288113. DOI: 10.3389/fmicb.2023.1192955.


antimicrobial efficacy of riboflavin, ultraviolet-A radiation, and combined riboflavin/ultraviolet-A radiation on ocular pathogens.

Sharma A, Sharma R, Chander J, Nirankari V Taiwan J Ophthalmol. 2023; 13(1):21-27.

PMID: 37252159 PMC: 10220446. DOI: 10.4103/tjo.tjo_28_21.


Riboflavin as a promising antimicrobial agent? A multi-perspective review.

Farah N, Chin V, Chong P, Lim W, Lim C, Basir R Curr Res Microb Sci. 2022; 3:100111.

PMID: 35199072 PMC: 8848291. DOI: 10.1016/j.crmicr.2022.100111.